2025-11-05T09:47:21-06:00 2025-06-30 363963131 MANN WEITZ & ASSOCIATES LLC 570 LAKE COOK ROAD SUITE 330 DEERFIELD IL 60015 990 2024-07-01 366102182 LEUKEMIA RESEARCH FOUNDATION LEUK 8474240600 191 WAUKEGAN ROAD 105 NORTHFIELD IL 60093 KEVIN RADELET EXECUTIVE DIRECTOR 8474240600 2025-11-05 1 1 MARCY STEINDLER P00573131 8472673400 2024 2025-03-06 01:10:19Z KEVIN RADELET 191 WAUKEGAN ROAD 105 NORTHFIELD IL 60093 10126362 0 X WWW.LEUKEMIARF.ORG X 1951 IL TO CURE LEUKEMIA BY FUNDING INNOVATIVE RESEARCH, AND TO SUPPORT PATIENTS AND FAMILIES. 13 13 6 150 0 0 2349551 5949301 0 0 141261 179266 4798 -92932 2495610 6035635 1657011 2100000 0 0 682621 754082 0 0 324885 270439 358404 2610071 3212486 -114461 2823149 6882073 10265211 2795411 3040287 4086662 7224924 X TO CURE LEUKEMIA BY FUNDING INNOVATIVE RESEARCH, AND TO SUPPORT PATIENTS AND FAMILIES. 0 0 2083182 1950000 RESEARCH GRANTS - IN FISCAL YEAR 2025, 13 RESEARCH GRANTS WERE AWARDED TO NEW INVESTIGATORS STUDYING LEUKEMIA OR MDS FROM US-BASED MEDICAL INSTITUTIONS. EACH GRANT AWARD IS $150,000 OVER A TWO-YEAR PERIOD, WITH TOTAL RESEARCH FUNDING OF $1.95 MILLION. RESEARCH GRANT AWARDS WERE SELECTED BASED ON RECOMMENDATIONS FROM THE FOUNDATION'S INDEPENDENT MEDICAL ADVISORY BOARD AFTER A RIGOROUS GRANT REVIEW PROCESS. 307925 PATIENT EDUCATION AND SUPPORT - IN FY25, THE FOUNDATION DELIVERED 11 VIRTUAL EDUCATION PROGRAMS FOR PATIENTS AND CAREGIVERS. THESE PROGRAMS WERE ORGANIZED WITHIN OUR TWO ANNUAL SERIES (LEUKEMIA Q&A AND NEW & EMERGING TREATMENTS), A LEUKEMIA AWARENESS MONTH SERIES (CANCER AND FINANCES AND MINDFULNESS), AND A SPRING SERIES (GENETICS AND NUTRITION). MORE THAN 1,500 INDIVIDUALS REGISTERED FOR THESE PROGRAMS, AND 86% OF PARTICIPANTS RATED THEM AS EXCELLENT OR VERY GOOD.IN ADDITION, FOUR NEW EDUCATIONAL PAGES WERE ADDED TO OUR WEBSITE, PROVIDING INFORMATION ABOUT TESTS ORDERED BY CLINICIANS, WHAT THEY REVEAL, AND HOW THEY GUIDE TREATMENT DECISIONS. THE NEW RESOURCES INCLUDE DIAGNOSIS AND TESTING, LEUKEMIA BLOOD TESTS, BONE MARROW TESTS FOR LEUKEMIA, AND LEUKEMIA BIOMARKER TESTING. 217956 150000 PATIENT GRANT PROGRAM - IN FISCAL YEAR 2025, 100 FINANCIAL ASSISTANCE GRANTS OF UP TO $1,500 WERE AWARDED TO PATIENTS. THIS NEED-BASED PROGRAM ASSISTS LEUKEMIA PATIENTS AND THEIR FAMILIES BY EASING THE FINANCIAL BURDEN THAT COMES WITH A LEUKEMIA DIAGNOSIS SO THE FOCUS CAN BE ON HEALTH AND TREATMENT. GRANT AWARDS CAN BE USED FOR ANY EXPENSE, INCLUDING MEDICAL BILLS, MEDICATIONS, TRANSPORTATION AND LODGING EXPENSES, RENT, FOOD, AND MORE. 2609063 1 1 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 1 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 1 6 1 0 0 0 0 0 0 0 0 0 0 0 0 X 13 13 1 0 0 0 0 0 0 1 1 0 1 1 1 1 1 1 1 1 1 0 0 CA FL GA IL MD MA MI MT NJ NC NY OK TN RI OR UT VA WV WI NV CO CT ME MO OH TX WA NM AL PA ND KS KY MS MN NV NH SC WI HI AK AR DC X X ARLEEN BOUDART 8474240600 191 WAUKEGAN ROAD SUITE 105 NORTHFIELD IL 60093 BLAKE BRANDWEIN PRESIDENT 0.50 X X 0 0 0 GERALD BRIN TREASURER 0.50 X X 0 0 0 PATTY MIX SECRETARY 0.50 X X 0 0 0 ROBERT GRABEMANN GENERAL COUNSEL 0.50 X 0 0 0 TAMAR UZIEL AT LARGE MEMBER 0.50 X 0 0 0 JAIME MORAN AT LARGE MEMBER 0.50 X 0 0 0 JOE GARBARSKI AT LARGE MEMBER 0.50 X 0 0 0 TODD HOLMES AT LARGE MEMBER 0.50 X 0 0 0 RUSS WARNER AT LARGE MEMBER 0.50 X 0 0 0 LARRY MIX AT LARGE MEMBER 0.50 X 0 0 0 RANDI SCHULLO AT LARGE MEMBER 0.50 X 0 0 0 STEVE WILENSKY AT LARGE MEMBER 0.50 X 0 0 0 SAVYON AMIT VICE PRESIDENT 0.50 X X 0 0 0 KEVIN RADELET EXECUTIVE DIRECTOR 37.50 X 155655 0 20858 155655 0 20858 1 0 1 0 0 16548 160629 5772124 5949301 160672 160672 3824196 3805602 18594 18594 18594 168582 160629 285125 -116543 -116543 10690 0 10690 10690 OTHER INCOME 900099 12921 12921 12921 6035635 12921 0 73413 1950000 1950000 150000 150000 189415 103553 34095 51767 459649 251290 82737 125622 14606 7985 2629 3992 44676 24424 8042 12210 45736 25004 8232 12500 24855 24855 6838 6838 2214 2214 58690 21044 22386 15260 17021 9230 3442 4349 71793 19713 37696 14384 1263 1263 14546 13190 599 757 658 357 133 168 14503 2547 5167 6789 PUBLIC RELATIONS 60472 16944 34369 9159 FUNDRAISING CAMPAIGNS 49728 12882 36846 SPECIAL EVENTS SUPPLIES 17114 17114 MARKETING 7299 7299 11410 900 5104 5406 3212486 2609063 278538 324885 2780311 2370348 1960396 2538550 305038 792095 13454 8512 27480 136168 135171 1655 997 1306806 3999153 519355 523134 6882073 10265211 14300 14326 2685682 2814077 152460 95429 59424 2795411 3040287 X 3555696 6674996 530966 549928 4086662 7224924 6882073 10265211 X 2823149 96564 118680 99869 X 0 1 X 1 0 X 2574542 2923993 4111876 2349551 5949301 17909263 2574542 2923993 4111876 2349551 5949301 17909263 3985067 13924196 14471 6619 90927 142447 160672 415136 3755 144 4798 12921 21618 18346017 0.75900 0.87630 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 86899 3000000 100531 511 3186919 86084 1514 699 86899 85526 688 130 86084 85360 305 139 85526 84594 1220 454 85360 0.97000 0.03000 0 0 99358 98361 997 36810 36810 0 997 SECURITY DEPOSIT 4663 BENEFICIAL INTEREST IN TRUST 462175 OPERATING RIGHT-OF-USE ASSETS 56296 523134 OPERATING LEASE LIABILITIES 59424 59424 X 6225230 96564 99869 196433 6028797 6838 6838 6035635 3205648 0 3205648 6838 6838 3212486 PART V, LINE 4: THE EARNINGS OF THE FUND ARE TO BE USED TO PROVIDE ASSISTANCE TO PATIENTS AND THEIR FAMILIES AND TO FUND MEDICAL RESEARCH. PART X, LINE 2: THE FINANCIAL STATEMENT EFFECTS OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN ARE RECOGNIZED IN THE FINANCIAL STATEMENTS WHEN IT IS MORE LIKELY THAN NOT, BASED ON THE TECHNICAL MERITS, THAT THE POSITION WILL BE SUSTAINED UPON EXAMINATION. AS OF JUNE 30, 2025, THE FOUNDATION HAD NO UNCERTAIN TAX POSITIONS THAT QUALIFY FOR RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. PART XI, LINE 2D - OTHER ADJUSTMENTS: CANCELLATION OF GRANTS 61,761. CHANGE IN BENEFICIAL INTEREST 38,108. JOEY'S ANGELS GOLF EVENT 144059 24053 120006 33537 106719 500 1471 ALAN BRIN SKI TRIP 95350 46774 48576 676 32504 1405 1 89802 89802 30778 66589 9634 1312 329211 160629 168582 64991 205812 11539 2783 285125 -116543 1 THE UNIVERSITY OF CHICAGO 6054 S DREXEL AVE SUITE 300 CHICAGO IL 60637 362177139 501(C)(3) 150000 0 NEW INVESTIGATOR RESEARCH GRANT NORTHWESTERN UNIVERSITY FEINBERG SCHOOL OF MEDICINE 750 N LAKE SHORE DRIVE RUBLOFF 7TH FLOOR CHICAGO IL 60611 362167817 501(C)(3) 150000 0 NEW INVESTIGATOR RESEARCH GRANT MILLER SCHOOL OF MEDICINE OF THE UNIVERSITY OF MIAMI 1531 BRESCIA AVE SUITE 124 CORAL GABLES FL 33146 590624458 501(C)(3) 150000 0 NEW INVESTIGATOR RESEARCH GRANT UNIVERSITY OF PITTSBURGH CANCER INSTITUTE 350 THACKERAY HALL PITTSBURGH PA 15260 250965591 501(C)(3) 150000 0 NEW INVESTIGATOR RESEARCH GRANT WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST LOUIS ONE BROOKINGS DRIVE ST LOUIS MO 63030 430653611 501(C)(3) 150000 0 NEW INVESTIGATOR RESEARCH GRANT THE UNIVERSITY OF TEXAS MD ANDERSON 1515 HOLCOMBE BLVD HOUSTON TX 77030 746001118 501(C)(3) 150000 0 NEW INVESTIGATOR RESEARCH GRANT BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE 1500 EAST DUARTE ROAD DUARTE CA 91010 953435919 501(C)(3) 150000 0 NEW INVESTIGATOR RESEARCH GRANT WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY 1300 YORK AVE NEW YORK NY 10065 131623978 501(C)(3) 150000 0 NEW INVESTIGATOR RESEARCH GRANT MASSACHUSETTS GENERAL HOSPITAL 13TH ST BLDG 149 CHARLESTON MA 02129 042697983 501(C)(3) 150000 0 NEW INVESTIGATOR RESEARCH GRANT NORTHWESTERN UNIVERSITY - CHICAGO CAMPUS RUBLOFF BUILDING 7TH FLOOR 750 NORTH LAKE SHORE DRIVE CHICAGO IL 60611 362167817 501(C)(3) 150000 0 NEW INVESTIGATOR RESEARCH GRANT WASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST LOUIS 660 SEUCLID AVE CAMPUS BOX 8233 ST LOUIS MO 63130 362167817 501(C)(3) 150000 0 NEW INVESTIGATOR RESEARCH GRANT REGENTS OF THE UNIVERSITY OF MINNESOTA - TWIN CITIES 450 MCNAMARA ALUMNI CENTER 200 OAK STREET SE MINNEAPOLIS MN 55455 416007513 501(C)(3) 150000 0 NEW INVESTIGATOR RESEARCH GRANT CITY OF HOPE COMPREHENSIVE CANCER CENTER 1500 EAST DUARTE ROAD DUARTE CA 91010 951683875 501(C)(3) 150000 0 NEW INVESTIGATOR RESEARCH GRANT 13 MEDICAL FINANCIAL ASSISTANCE 100 150000 PART I, LINE 2: THE FINAL SCIENTIFIC REPORT SHOULD BE RECEIVED WITHIN 30 DAYS OF COMPLETION OF THE PROJECT. GRANTEES ARE REQUIRED TO COMPLETE THE FINAL SCIENTIFIC REPORT FORM AND E-MAIL THE FOUNDATION WITH A BRIEF SCIENTIFIC SUMMARY, A BRIEF LAY SUMMARY, AND A LIST OF ANY RESULTING PUBLICATIONS. X X X 0 0 0 0 0 0 0 0 0 KEVIN RADELET EXECUTIVE DIRECTOR 155655 0 0 0 0 0 4899 0 15959 0 176513 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 LARRY AND PATTY MIX HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11B THE FINANCE DIRECTOR AND EXECUTIVE DIRECTOR REVIEW FORM 990. THE FINAL DRAFT OF FORM 990 IS MADE AVAILABLE TO ALL BOARD MEMBERS PRIOR TO FILING. MEMBERS ARE NOTIFIED THAT FORM 990 HAS BEEN POSTED AND THEY CAN ACCESS A URL AND PUT IN THEIR PASSWORD TO VIEW THE DOCUMENT. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS REVIEWED ANNUALLY AND MONITORED AS POTENTIAL REFERENCE AND/OR ACTION IS CALLED FOR. FORM 990, PART VI, SECTION B, LINE 15A THE EXECUTIVE DIRECTOR'S SALARY IS DETERMINED BY A COMPENSATION SURVEY. WE USE A WRITTEN EMPLOYMENT CONTRACT THAT IS APPROVED BY THE BOARD FORM 990, PART VI, SECTION C, LINE 19 WE MAKE OUR GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE UPON REQUEST. THE FINANCIAL STATEMENTS ARE AVAILABLE ONLINE AND UPON REQUEST. FORM 990, PART XI, LINE 9: CHANGE IN VALUE OF BENEFICIAL INTEREST IN TRUST 38,108. CANCELLATION OF GRANTS 61,761.